Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseTissue DonorsBone MarrowHistocompatibility TestingBone Marrow CellsHistocompatibilityGraft SurvivalWhole-Body IrradiationTransplantation ChimeraAnemia, AplasticLeukemiaTransplantation ConditioningTransplantation, AutologousHematopoietic Stem Cell TransplantationBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocyte TransfusionRecurrenceRadiation ChimeraBone and BonesSurvival AnalysisHematopoietic Stem CellsTransplantation, IsogeneicGraft RejectionGraft vs Host ReactionLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideBone Marrow PurgingHematologic NeoplasmsMice, Inbred C57BLImmunosuppressionImmunosuppressive AgentsLeukemia, Myeloid, AcuteHLA AntigensGraft vs Tumor EffectAcute DiseaseLiver TransplantationRemission InductionTreatment OutcomeTime FactorsT-LymphocytesTransplantation ImmunologyCombined Modality TherapyHepatic Veno-Occlusive DiseaseHematopoiesisLeukemia, MyeloidLymphocyte TransfusionGraft vs Leukemia EffectChimeraActuarial AnalysisKidney TransplantationBone Marrow DiseasesMyelodysplastic SyndromesTransplantation ToleranceNuclear FamilyCyclosporineBone Marrow ExaminationRetrospective StudiesGraft Enhancement, ImmunologicSkin TransplantationMice, Inbred BALB CLymphoma, Non-HodgkinHematologic DiseasesHeart TransplantationDisease-Free SurvivalSevere Combined ImmunodeficiencyCytomegalovirus InfectionsBone Marrow NeoplasmsChimerismSurvival RateFatal OutcomeStem Cell TransplantationCytarabineBone RemodelingAntineoplastic Combined Chemotherapy ProtocolsLymphocyte Culture Test, MixedColony-Forming Units AssayPancytopeniaLiving DonorsSpleenFollow-Up StudiesLeukocyte CountGranulocyte Colony-Stimulating FactorBlood DonorsFlow CytometryMice, Inbred C3HLymphomaEtoposideMultiple MyelomaTissue and Organ ProcurementInfectionCell DifferentiationImmune ToleranceLung TransplantationMethotrexateAntilymphocyte SerumImmunophenotyping